Mersana Therapeutics, Inc.【MRSN】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
3Q25 12,182 -17.7%
2Q25 16,218 -6.0%
1Q25 18,341 -1.8%
4Q24 22,286 +3.7%
3Q24 14,803 -51.5%
2Q24 17,245 -64.8%
1Q24 18,686 -60.5%
4Q23 21,495 -53.0%
3Q23 30,531 -39.7%
2Q23 48,968 +18.8%
1Q23 47,275 +32.0%
4Q22 45,709 +22.3%
3Q22 50,639 +43.6%
2Q22 41,231 +29.0%
1Q22 35,806 +30.6%
4Q21 37,368 +63.5%
3Q21 35,275 +113.2%
2Q21 31,955 +107.3%
1Q21 27,415 +124.4%
4Q20 22,858 +83.9%
3Q20 16,546 +20.8%
2Q20 15,413 +12.0%
1Q20 12,219 -19.3%
4Q19 12,430 -37.3%
3Q19 13,701 -9.7%
2Q19 13,766 +8.7%
1Q19 15,143 +23.6%
4Q18 19,816 +36.1%
3Q18 15,180 +33.0%
2Q18 12,663 +19.2%
1Q18 12,256 -
4Q17 14,555 -
3Q17 11,412 -
2Q17 10,627 -